Key Summary
- Gut health, obesity, and related metabolic conditions
- Development of symbiotic supplements (prebiotics + probiotics) to improve glucose, cholesterol, and overall metabolic health
- Identify biomarkers to monitor health trajectories and create scalable prevention solutions
Novonesis and Novo Nordisk will collaborate to study the intricate relationships between gut health and metabolic conditions.
They aim to focus on health concerns such as obesity and its related consequences.
Obesity is a pressing global health issue that has the potential to cause conditions like type 2 diabetes and cardiovascular disease.
The project is focused on producing symbiotic food supplements consisting of prebiotics and probiotics.
These products could potentially benefit in the maintenance of health parameters like blood glucose and cholesterol levels.
The researchers aim to provide supplements with dual benefits.
The probiotic microorganisms confer the health benefits, while prebiotics support the probiotics, ensuring improved metabolic health among the people.
The study will also investigate how the gut microbiome can be used to monitor and predict individual health trajectories.
It will explore novel biomarkers to assess the efficacy of microbiome-based interventions.
“At Novonesis, we are committed to advancing our understanding of the human microbiome and its crucial role in digestion, immunity, mood and overall wellbeing,” said Henrik Joerck Nielsen, executive vice president of human health biosolutions and strategy at Novonesis.
He added, “ This collaboration with Novo Nordisk will deepen our insights into the gut microbiome’s role in metabolic health and help us identify innovative products that support it.
”Professor Nadeem Sarwar, corporate vice president and head of the Transformational Prevention Unit in Obesity at Novo Nordisk said, “Obesity is a complex disease influenced by multiple factors, including hormones and genetics.
”“Our understanding of the gut's role in maintaining metabolic health is evolving, and this collaboration is crucial for developing scalable, science-based solutions to prevent obesity and its consequences,” he said.
